Skip to Content


In the US, Isavuconazonium (isavuconazonium systemic) is a member of the drug class azole antifungals and is used to treat Aspergillosis - Invasive and Mucormycosis - Invasive.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antifungal agent

Chemical Name


Foreign Names

  • Isavuconazonium (Latin)
  • Isavuconazonium-Kation (German)
  • Isavuconazonium (French)
  • Isavuconazonio (Spanish)

Generic Names

  • Isavuconazonium (OS: USAN)
  • BAL 8557 (IS)
  • BAL 8557-000 (IS)
  • Isavuconazonium ion (IS)
  • UNII-VH2L779W8Q (IS)
  • Isavuconazonium Sulfate (OS: USAN)
  • BAL 8557-002 (IS)
  • UNII-31Q44514JV (IS)

Brand Names

  • Cresemba
    Astellas, United States; Basilea, Germany; Basilea, Estonia; Basilea, Netherlands; Basilea, Norway; Basilea Pharmaceutica, United Kingdom; Unimedic, Denmark; Unimedic, Sweden; Unimedic Pharma, Finland
  • Cresemba 100mg
    Basilea Medical, Austria; Basilea Pharmaceutica, Switzerland
  • Cresemba 200mg
    Basilea Medical, Austria; Basilea Pharmaceutica, Switzerland


ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.